Genentech Xolair
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The asthma agent may get reviewed at the tentatively scheduled April 26-27 Pulmonary-Allergy Drugs Advisory Committee meeting. Genentech is planning to submit additional platelet monitoring data in time for the meeting. "It is our absolute intention to get all of the data into the FDA to assure that we have a successful advisory committee if we are invited to participate" in the meeting, Genentech Chief Medical Officer Susan Desmond-Hellmann, MD, said during a conference call Jan. 18. The firm believes it is on track for a summer approva
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.